EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

X and Y Differences in Melanoma Survival Between the Sexes

Peter Hersey iD, Hsin-Yi Tseng iD, Sara Alavi iD, Jessamy Tiffen iD

Pigment Cell & Melanoma Research · 2025-01 · 38 (1)

DOI: 10.1111/pcmr.13194 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pigment Cell & Melanoma Research, online erschienen am 23.08.2024. Verfasst von Peter Hersey und 3 weiteren Autor:innen. Beteiligte Einrichtung: Melanoma Immunology and Oncology Program, the Centenary Institute, University of Sydney, Camperdown, New South Wales, Australia. Hauptthemen laut MEDLINE: Chromosomes, Human, X, Chromosomes, Human, Y, Melanoma, Skin Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Cancer Institute NSW, Cancer Council NSW, Australian Melanoma Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Marked differences in survival from melanoma are noted between men and women that cannot be accounted for by behavioral differences. We and others have provided evidence that this difference may be due to increased expression of immune‐related genes from the second X chromosome because of failure of X inactivation. In the present review, we have examined evidence for the contrary view that survival differences are due to weaker immune responses in males. One reason for this may be the loss of Y chromosomes (LOY), particularly in older males. The genes involved may have direct roles in immune responses or be noncoding RNAs that regulate both sex and autosomal genes involved in immune responses or tumor growth. Loss of the KDM6C and KDM5D demethylases appeared to common genes involved. The second factor appears to be the activation of androgen receptors (AR) on melanoma cells that increase their invasiveness and growth. Induction of T‐cell exhaustion by AR that limits immune responses against melanoma appeared a common finding. The development of treatments to overcome effects related to gene loss on Y poses challenges, but several avenues related to AR signaling appear worthy of further study in the treatment of metastatic disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chromosomes, Human, XChromosomes, Human, YMelanomaSkin NeoplasmsAnimalsFemaleHumansMaleReceptors, AndrogenSex Factors

Stichwörter der Autor:innen

KDM5DKDM6C noncoding RNAsPRC1 complexesX chromosomeandrogen receptorsdemethylasesloss of Y chromosomemelanomaoverall survival

Substanzen

Receptors, Androgen

Autor:innen und Institutionen

  • Melanoma Immunology and Oncology Program, the Centenary Institute, University of Sydney, Camperdown, New South Wales, Australia.
  • Melanoma Institute Australia, Sydney, New South Wales, Australia.
  • Faculty of Medicine and Health, School of Medical Sciences, University of Sydney, Camperdown, New South Wales, Australia.
  • Melanoma Epigenetics Lab, the Centenary Institute, University of Sydney, Camperdown, New South Wales, Australia.

ORCID-Profile: Peter Hersey, Hsin-Yi Tseng, Sara Alavi, Jessamy Tiffen

Förderung

  • Cancer Institute NSW
  • Cancer Council NSW
  • Australian Melanoma Research Foundation

Zitieren

APA

Hersey, P., Tseng, H. Y., Alavi, S., & Tiffen, J. (2025). X and Y Differences in Melanoma Survival Between the Sexes. Pigment Cell & Melanoma Research, 38(1). https://doi.org/10.1111/pcmr.13194

Vancouver

Hersey P, Tseng HY, Alavi S, Tiffen J. X and Y Differences in Melanoma Survival Between the Sexes. Pigment Cell & Melanoma Research. 2025;38(1). doi:10.1111/pcmr.13194

BibTeX
@article{Hersey2025,
  author = {Hersey, Peter and Tseng, Hsin-Yi and Alavi, Sara and Tiffen, Jessamy},
  title = {X and Y Differences in Melanoma Survival Between the Sexes},
  journal = {Pigment Cell & Melanoma Research},
  year = {2025},
  volume = {38},
  number = {1},
  doi = {10.1111/pcmr.13194}
}
Kostenlos starten →